Advances in Biologic Therapies
Case: Challenges in Clinical Immunology
Release Date: August 11, 2016
Expiration Date: August 11, 2018
Estimated Time of Completion: 15 minutes
Advances in Biologic Therapies is a webcast series that provides clinicians with a review of the use of biologic agents in the fields of rheumatology, dermatology, allergy, and infectious disease.
This webcast discusses challenges in clinical immunology, including autoimmune, autoinflammatory and immunodeficiency diseases.
- Review checkpoint inhibitors and their role in controlling immune proliferation.
- Identify how checkpoints can be exploited in chronic immune activation and exhaustion.
- Describe cancer immunotherapy and target checkpoints for chronic infectious diseases.
These activities are directed to rheumatologists, dermatologists, allergists, infectious disease practitioners, internal medicine physicians, pulmonologists, nurse practitioners, physician assistants, and other health care professionals caring for patients with immunologic diseases.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Activity Director and Faculty
Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic
Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic and Rheumatologic Institute
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
|Leonard H. Calabrese, DO|
|GSK, Pfizer, Inc., Sanofi Aventis, UCB||Consulting|
|AbbVie Pharmaceuticals, BMS, Genentech/Roche, Janssen||Consulting; Teaching and Speaking|
||Teaching and Speaking|
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:
This CME activity was produced by Cleveland Clinic Center for Continuing Education and
R.J. Fasenmyer Center for Clinical Immunology.